Endocyte's Investigational Diagnostic Imaging Agent Etarfolatide Identifies Ovarian Cancer and Non-Small Cell Lung Cancer Patients Most Likely to Benefit From Folate Receptor-Targeted Treatment, New Analysis Shows - 3.1.13 Endocyte, Inc. (ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs)... Read More >>

ShareThis Ranked 35 on Forbes Most Promising Companies List - 2.6.13 ShareThis, the company that connects audiences to publishers and advertisers through sharing, announced it... Read More >>